Interactive Drug Benefit List
DIN/NPN/ PIN Generic Name Product Name, Strength & Dosage Form Unit Price, Unit of Issue Manufacturer LCA Price MAC Price Interchangeable Products Coverage Status
02076306 APRACLONIDINE HCL IOPIDINE 0.5 % OPHTHALMIC SOLUTION 5.3700
ML
ESS N/A N/A NO REGULAR BENEFIT Details
02485605 CYSTEAMINE HYDROCHLORIDE CYSTADROPS 0.37 % OPHTHALMIC SOLUTION 397.2000
ML
RRD N/A N/A NO SPECIAL AUTHORIZATION Details
80024901 SODIUM CHLORIDE SALINEX (DROPS) 0.9 % NASAL SOLUTION 0.1650
ML
EXP N/A N/A NO REGULAR BENEFIT Details
DIN/NPN/ PIN 02076306
Generic Name APRACLONIDINE HCL
Product Name, Strength & Dosage Form IOPIDINE 0.5 % OPHTHALMIC SOLUTION
Unit Price, Unit of Issue 5.3700
Manufacturer ESS
LCA Price N/A
MAC Price N/A
Interchangeable Products NO
Coverage Status REGULAR BENEFIT
Details
DIN/NPN/ PIN 02485605
Generic Name CYSTEAMINE HYDROCHLORIDE
Product Name, Strength & Dosage Form CYSTADROPS 0.37 % OPHTHALMIC SOLUTION
Unit Price, Unit of Issue 397.2000
Manufacturer RRD
LCA Price N/A
MAC Price N/A
Interchangeable Products NO
Coverage Status SPECIAL AUTHORIZATION
Details
DIN/NPN/ PIN 80024901
Generic Name SODIUM CHLORIDE
Product Name, Strength & Dosage Form SALINEX (DROPS) 0.9 % NASAL SOLUTION
Unit Price, Unit of Issue 0.1650
Manufacturer EXP
LCA Price N/A
MAC Price N/A
Interchangeable Products NO
Coverage Status REGULAR BENEFIT
Details
To return to the printable Drug Benefit List and related publications, click here
Last Updated:
NOTICE:
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.
Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.
Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL), and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.